Vir Biotechnology :
VIR
VIR
Stock Data
$6.69
$0.06 (0.91%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Vir Biotechnology Inc is a pioneering immunology company focused on developing treatments for serious infectious diseases. With a robust pipeline, it targets conditions like chronic hepatitis, HIV, respiratory viruses, influenza, HPV lesions, and COVID-19. The company collaborates with notable organizations and companies, including the Bill & Melinda Gates Foundation, National Institutes of Health, and GlaxoSmithKline, to advance its research and development efforts. Founded in 2016 and based in San Francisco, Vir Biotechnology leverages partnerships and cutting-edge science to create solutions for global health challenges.
All Vir Biotechnology Articles
11 Articles